SLC30A9 and diffuse large B-cell lymphoma: In summary, we revealed that NAT10 promoted progression of DLBCL via mediating ac4C acetylation of SLC30A9 mRNA and regulating AMPK‐mTOR‐p70(S6K) signalling pathway (Figure 8).